Abbott's $335 M HIV buy

Article Abstract:

Abbott Park, IL-based Abbott Laboratories will significantly expand its antiviral portfolio with a deal involving Durham, NC-based Triangle Pharmaceuticals. Abbott presently owns two HIV proteaseinhibitors (Norvir, approved and ABT-378, in phase III development). Triangle owns three nucleoside reverse transcriptase inhibitors and one non-nucleoside reverse transcriptase inhibitor for treatment of HIV and HBV. Abbott will buy Triangle shares and provide $31.7 million in research funding. Both companies will share profits.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code:

Aurora throws light on Vertex's aspirations

Article Abstract:

Cambridge, MA-based genomics-based drug discovery and development company Vertex Pharmaceuticals recently announced that it will acquire San Diego, CA-based leading bioassay provider Aurora Biosciences.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code:

Warner Lambert acquires speculative Agouron pipeline

Article Abstract:

Warner-Lambert acquired San Diego, California-based Agouron Pharmaceuticals for $2.1 billion in stock.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code: